Managed Care Pharmacy Issues

Stay updated on the latest managed care pharmacy issues with our comprehensive resources. Explore key topics, current challenges, and expert insights to enhance your practice and advocate for better health care solutions. Learn more about our advocacy with our pharmacy practice positions.

Managed Care - Stock Image

Featured

Featured

High-Investment-Medications Predictability Affordability and Accessibility Report - Cover

High-Investment Medications: Predictability, Affordability, and Accessibility

The FDA continues to approve novel therapies, but concerns arise due to the costs of certain treatments. To address this, the AMCP organized a forum to explore solutions. Stakeholders recognize the benefits of high-investment medications, but uptake of payment strategies has been slow. Gradual changes, education, and collaboration are essential to improve predictability, affordability, and accessibility for patients.
Drug Pricing, Managed Care Practice Issues, Drug Pricing, Payment Systems, Payment Systems, Drug Pricing
Addressing-Evidence-Gaps-in-Accelerated Approval Programs Payer Perspectives - Cover

Addressing Evidence Gaps in the FDA Accelerated Approval: Payer Perspectives

AMCP convened key stakeholders in managed care to address the balance between patient access and payer requirements in the FDA Accelerated Approval (AA) pathway program. Experts from various fields participated, aiming to identify gaps between FDAAA requirements and payer-valued treatment outcomes, explore evidence ecosystem opportunities, and evaluate policy options. The forum emphasized supporting drug development innovation while recognizing payer needs and promoting stakeholder trust in the AA review process. Notably, incentivizing confirmatory trials emerged as a potential impactful policy solution.
Legislation & Regulation, Managed Care Practice Issues, Expedited Approval
Health Technology Assessment and Value Assessment Overview

Health Technology Assessment and Value Assessment Frameworks to Inform Coverage Reimbursement

Discover how health technology assessment (HTA) and value assessment frameworks play a crucial role in evaluating pharmaceuticals and health interventions. The recent multistakeholder Partnership Forum, hosted by AMCP, delved into recognizing value within resource constraints. Key takeaways include emphasizing innovative pharmaceutical products, comprehensive data, and the need for trusted value assessments in healthcare decision-making. Explore best practices for enhancing value assessment tools and processes across the industry.
Formulary & Utilization Management, Value Framework, Health Technology, Health Information Technology, Managed Care Practice Issues